Time‑Critical Benchmarks in Acute Coronary Syndrome Management

ECG Acquisition and Interpretation

Obtain and interpret a 12‑lead ECG within 10 minutes of first medical contact to identify STEMI and direct patients to the appropriate pathway; this is a Class I, Level B recommendation in ACC/AHA and ESC guidelines. 1
If the initial ECG is nondiagnostic but clinical suspicion remains high, repeat ECGs every 15–30 minutes until diagnostic changes appear, ensuring early detection of evolving ST‑segment abnormalities. 2

Measure high‑sensitivity cardiac troponin as soon as possible after presentation, with results available within 60 minutes; rapid availability supports timely rule‑in or rule‑out of myocardial infarction. Class I, Level B (ACC/AHA). 3
For high‑sensitivity assays, repeat the troponin measurement 1–2 hours after the initial draw (0 h/1 h algorithm) to accelerate diagnostic decision‑making. Class I, Level B (ACC/AHA). 3
When conventional troponin assays are used, obtain a repeat sample 3–6 hours after the first draw to capture delayed rises in enzyme levels. Class IIa, Level B (ACC/AHA). 4
Both the ACC/AHA 2025 guideline and the ESC 2021 guideline endorse the 0 h/1 h (or 0 h/2 h) high‑sensitivity troponin algorithms as the preferred approach for rapid MI rule‑in/out. Class I, Level B (ACC/AHA) and Class I, Level A (ESC). 3

First‑medical‑contact‑to‑device time must be ≤90 minutes for patients taken directly to a PCI‑capable centre; this target is a Class I, Level B‑NR recommendation and is linked to mortality reduction. 1
Every additional 30‑minute delay in reperfusion is associated with a measurable increase in mortality, underscoring the critical nature of the 90‑minute benchmark. Class I, Level B‑NR (ACC/AHA). 2

Perform coronary angiography within 24 hours for high‑risk patients (elevated troponin, dynamic ST changes, GRACE score > 140, hemodynamic instability, or ongoing ischemia). Class I, Level B (ESC). 5
If a patient has ongoing ischemia, hemodynamic collapse, or life‑threatening arrhythmia, proceed to immediate angiography regardless of biomarker or ECG findings. Class I, Level C (ESC). 6

The 10‑minute ECG target includes immediate interpretation by an experienced clinician, not merely acquisition; delays in physician review compromise the time‑sensitive triage. Class I, Level B (ACC/AHA). 2
Using a conventional troponin assay with a 1‑hour repeat interval (appropriate only for high‑sensitivity assays) can lead to premature discharge of patients with evolving MI; assay type must dictate repeat‑testing timing. Class IIa, Level B (ACC/AHA). 3
ST‑segment depression in anterior leads may mask posterior STEMI; obtaining posterior leads (V7‑V9) is essential when this pattern is seen to avoid misclassification and delayed reperfusion. Class IIa, Level C (ACC/AHA). 7
The 90‑minute FMC‑to‑device metric incorporates transfer time from non‑PCI facilities; if the target cannot be met, fibrinolytic therapy should be administered promptly at the presenting hospital. Class I, Level B (ACC/AHA). 1

The European Society of Cardiology recommends that all patients with suspected acute coronary syndrome (ACS) must be seen immediately by a qualified physician, with a 12-lead ECG obtained within 10 minutes of first medical contact to guide the treatment pathway 8, 9, 10, 11.
The American Heart Association suggests that symptom evaluation should include documentation of chest pain quality, duration, radiation, and associated symptoms (dyspnea, diaphoresis, nausea, lightheadedness) 8, 10, 11.
The European Heart Journal recommends that physical examination should assess hemodynamic stability, signs of heart failure (S3 gallop, pulmonary rales, new mitral regurgitation), and peripheral perfusion 12, 13.

The American College of Cardiology recommends that patients with ST-segment elevation myocardial infarction (STEMI) should have immediate activation of the catheterization lab for primary percutaneous coronary intervention (PCI) within 120 minutes 9, 14.
The European Society of Cardiology suggests that for non-ST-elevation acute coronary syndrome (NSTE-ACS), coronary angiography should be performed within 24 hours in patients with high-risk criteria, such as elevated troponin, dynamic or new contiguous ST/T-segment changes, or a GRACE risk score >140 9, 13, 14.

The American Heart Association recommends that aspirin should be administered at a dose of 150-300 mg non-enteric loading dose, then 75-100 mg daily, and a P2Y12 inhibitor, such as ticagrelor or clopidogrel, should be given as a loading dose 8, 9, 10, 11, 15.
The European Heart Journal suggests that anticoagulation with fondaparinux, enoxaparin, or unfractionated heparin should be initiated immediately, with the choice of agent depending on the clinical scenario and patient characteristics 8, 10, 11, 16.

The European Society of Cardiology recommends that high-sensitivity troponin or cardiac troponin T/I should be measured on arrival and at 3-6 hours, with any rise in troponin indicating a high-risk pathway 8, 9, 10, 11, 12.
The American College of Cardiology suggests that the GRACE risk score should be calculated to guide decision-making regarding the need for invasive strategy and intensity of medical therapy 14.

The European Heart Journal recommends that patients with chronic kidney disease should receive the same diagnostic and therapeutic strategies as those without kidney disease, with dose adjustments as needed 9, 14.
The American Heart Association suggests that elderly patients (≥75 years) should receive the same interventional strategies as younger patients, with consideration of bleeding risk and adjustment of antithrombotic dosing for renal function 9, 14.